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Heme proteins can perform a variety of electrochemical functions. While natural heme proteins carry out particular functions selected by
biological evolution, artificial heme proteins, in principle, can be tailored to suit specified technological applications. Here we describe initial
characterization of the electrochemical properties of a de novo heme protein, S824C. Protein S824C is a four-helix bundle derived from a library
of sequences that was designed by binary patterning of polar and nonpolar amino acids. Protein S824C was immobilized on a gold electrode and
the formal potential of heme–protein complex was studied as a function of pH and ionic strength. The binding of exogenous N-donor ligands to
heme/S824C was monitored by measuring shifts in the potential that occurred upon addition of various concentrations of imidazole or pyridine
derivatives. The response of heme/S824C to these ligands was then compared to the response of isolated heme (without protein) to the same
ligands. The observed shifts in potential depended on both the concentration and the structure of the added ligand. Small changes in structure of
the ligand (e.g. pyridine versus 2-amino pyridine) produced significant shifts in the potential of the heme–protein. The observed shifts correlate to
the differential binding of the N-donor molecules to the oxidized and reduced states of the heme. Further, it was observed that the electrochemical
response of the buried heme in heme/S824C differed significantly from that of isolated heme. These studies demonstrate that the structure of the de
novo protein modulates the binding of N-donor ligands to heme.
© 2006 Elsevier B.V. All rights reserved.Keywords: Protein design; Binary patterning; Cyclic voltammetry; Redox protein; Heme protein1. Introduction
Proteins have the ability (i) to bind target compounds with
high affinity and exquisite selectivity, and (ii) to signal such
binding events by a variety of mechanisms. These properties
render proteins ideally suited for use in a variety of sensing
applications. Redox proteins are particularly attractive as
sensors because changes induced by ligand binding can be
detected optically and/or electrochemically, thereby obviating
the need for additional detection reagents [1–4].
Naturally occurring proteins, however, have several draw-
backs that can limit their usefulness in technological applica-
tions. Natural proteins were selected by evolution to perform
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doi:10.1016/j.bpc.2006.04.011Because these functions–and the environments in which they
evolved–may differ substantially from those required by
technological applications, the ‘evolutionary baggage’ associ-
ated with natural proteins may render them unsuitable for
incorporation into sensors or other devices. For these reasons,
we have begun to explore the electrochemical properties of
artificial redox proteins.
Our initial studies, reported herein, focus on the de novo
protein S824C. This protein is a variant of sequence S824,
which was chosen from a library of 102-residue proteins
designed to fold into four-helix bundles [5,6]. This library
was designed using the ‘binary code’ strategy, in which
each position in an amino acid sequence is designed to be
either polar or nonpolar, but the exact identity of each polar
and nonpolar residue is not specified, and is varied
combinatorially [7–9]. Initial characterization of several pro-
teins chosen arbitrarily from this library showed that the
majority of them form well-folded and/or native-like
structures [5,6].
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were not explicitly designed to bind heme. Nonetheless, protein
S824 and several other proteins from the libraries do in fact bind
heme [10]. We have shown previously that these de novo heme
proteins (i) readily cycle between oxidized and reduced states;
(ii) bind reversibly to small ligands (e.g. CO); and (iii) in some
cases catalyze redox (e.g. peroxidase) chemistry [11–13].
The 3-dimensional structure of protein S824 was solved at
high resolution and shown to be a well-ordered four-helix
bundle [6]. Because this structure was determined in the
absence of heme, the structural details of heme binding are not
known. However, given the well-packed core of apo-S824,
binding of the heme macrocycle must produce some structural
rearrangements. In the resulting heme–protein structure, the
heme is unlikely to be fully sequestered in the hydrophobic
core. The resulting access to water presumably accounts for the
relatively low reduction potential of S824 [13].
The reduction potential of heme/S824 was shown previously
to be −0.374 V (vs. Ag/AgCl). (The value was reported as
−0.174 V versus NHE [13].) This suggests that histidine (rather
than methionine) binds the heme iron [13]. (Cysteine can be
excluded because it does not occur in the sequence of S824.)
The sequence of S824 contains 12 histidines, and these polar
side chains are exposed to solvent in the NMR structure of the
apo-protein (Fig. 1). Upon heme binding, structural reorgani-
zation presumably moves histidines side chains into positions
consistent with binding to the partially buried macrocycle.
For the current studies, protein S824 was attached to a gold
electrode via an engineered Gly–Gly–Cys linker at the C-
terminal end. (The terminally modified protein is called
S824C.) Heme was bound to the protein and the electrochem-
ical response of this immobilized heme–protein was studied as a
function of pH and ionic strength. Further, the electrochemical
response of heme/S824C to added N-donor ligands was
measured for a series of imidazole derivatives and pyridineFig. 1. (a) Ribbon diagram of the four helix bundle protein S824 showing the plac
histidine residues in orange. Note that most of the histidine residues in the apo-protei
structure was determined in the apo form by Wei et al. [6].derivatives. To assess the role of the protein structure on the
properties of the bound heme, we compared our electrochemical
and ligand binding results for heme/S824C with those obtained
for isolated heme (without protein) immobilized on a gold
electrode.
2. Results
2.1. Immobilization and characterization of de novo heme
protein S824C
2.1.1. Attachment of the heme protein to a gold electrode
To facilitate attachment of the protein to a gold electrode, we
modified the original sequence S824 by elongating the gene to
encode a Gly–Gly–Cys tripeptide at the C-terminus of the
protein. The new protein is called S824C. Our method for
attaching S824C to the gold electrode is shown schematically in
Fig. 2. Initially, the electrode was coated with a cystamine
monolayer. The coated electrode was then reacted with the
bifunctional reagent N-succinimidyl-3-maleimidopropionate to
yield a maleimide functionalized electrode [14]. The resulting
electrode was then reacted with S824C to yield the immobilized
four-helix bundle. Finally, the immobilized protein was treated
with Fe (III) protoporphyrin IX to generate the immobilized
heme protein, as shown in Fig. 2.
2.1.2. Cyclic voltammetry of the immobilized heme protein
As shown in Fig. 3, cyclic voltammetry of heme/S824C
immobilized on a gold electrode revealed a single redox wave
with a formal potential (vs. Ag/AgCl/KCl) of E°=−0.350 V.
The formal potential was calculated as the average of the
cathodic and anodic peak potentials in the cyclic voltammogram
(CV).
The observed formal potential for heme/S824C immobi-
lized on the gold electrode is in close agreement with theement of histidine residues. (b) Head-on view of the structure showing the 12
n are exposed to the solvent, as specified by the binary code strategy. The NMR
Fig. 2. Stepwise assembly of the S824C/heme protein onto a gold electrode.
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Fig. 3. Cyclic voltammogram of the heme/S824C immobilized on a gold
electrode. The scan rate is 0.02 V/s. The redox potential is −0.350 V (versus Ag/
AgCl/KCl). The inset shows a plot of the peak cathodic current against the scan
rates varying from 0.02 to 0.5 V/s. The plot is linear as expected for a surface
immobilized species.
Fig. 4. Formal potential of heme/S824 as a function of pH. Potentials were
recorded at 0.02 V/s in a mixed buffer system. Solutions were buffered from pH
4.2 to pH 5.6 with sodium acetate/acetic acid buffer; from pH 5.8 to pH 6.8 with
sodium phosphate buffer; and from pH 7 to pH 8.2 with Tris/HCl buffer. All
buffers were at an ionic strength equivalent to 50 mM sodium phosphate buffer
at pH 7.4.
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solution by potentiometric titration [13]. This indicates that
attachment to the electrode yields a heme–protein complex
similar to that obtained in solution. The plot of current vs.
scan rate shown in the inset of Fig. 3 is linear and increases
with increasing scan rate, as is typical for surface immobilized
species [15,16].
2.1.3. Dependence of the midpoint potential on pH and ionic
strength
The formal potential for the electrochemical response of
heme/S824C is dependent on pH, as shown in Fig. 4. The
experimental data were fitted to a function involving the
titration of two groups, with different pKa values in either
oxidation state [17]. The pKa's obtained from the fit are 6.08
and 6.77 (oxidized) and 6.64 and 8.40 (reduced). The pH profile
of the de novo heme–protein is similar to natural cytochromes,
which typically have pKa values in the range of 6–7 [18].
The redox peaks diminish below pH 5.5 and are unobserv-
able at pH 4.5. At low pH, protonation of the ligating amino
acid residues would diminish heme binding. Moreover, the
surface itself can become protonated, which would disrupt
electrostatic interactions between the protein and the electrode.
Similarly, above pH 8.0 both redox peaks diminish. This could
be due to deprotonation of ligating amino acid residues. The
identities of the side chains responsible for the change of Em
with pH are not known since our present knowledge of the
structure of S824 is limited to the apo form.
The formal potential of heme/S824C was also studied as a
function of ionic strength. The ionic strength was varied from
I=128 mM to I=636 mM by adjusting the concentration of
sodium phosphate buffer at pH 7.4. Over this range, the peak
current increased almost proportional to the ionic strength.
However, the midpoint potential of the heme–protein did not
change significantly. This behavior can be contrasted with most
small heme proteins, for which the potentials are typically
sensitive to the ionic strength of the surrounding solution [19].
The observed insensitivity of the potential of heme/S-824C toionic strength suggests the heme in this protein is relatively
shielded from solvent.
2.2. Immobilization and characterization of isolated heme
To assess the role of the de novo protein scaffold on the
electrochemical behavior of the heme protein, we sought to
establish default values using immobilized heme in the absence
of protein. This immobilized heme is hereafter referred to as
“isolated heme.” Isolated heme was attached to a gold surface as
described below, and its electrochemical response was mea-
sured and compared with that of heme/S824C.
2.2.1. Attachment of isolated heme to gold electrode
The method for attaching heme to the gold electrode is
shown schematically in Fig. 5 [20]. Initially, the gold electrode
was coated with alkyl-thiols. A mixture of alkyl-thiols was used
such that a small percentage of them bore an activated
functional group (3,3′-dithiopropionic acid di-(N-succinimidyl
ester) for subsequent attachment of heme (see figure). To ensure
that hemes in the final product were independently reconstituted
with protein, only a small fraction of the thiols contained this
activated group. The coated gold electrode was then reacted
with 1,12 diaminododecane, which reacts with the thiols
bearing activated functional groups. Finally, the amine
terminated groups were covalently coupled to the carboxyl
groups on Heme (Fe (III) protoporphyrin IX), using EDC (1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide) coupling
agent. The resulting immobilized heme system has significant
advantages over free heme in solution, which tends to aggregate
and precipitate.
2.2.2. Cyclic voltammetry of immobilized heme
As shown in Fig. 6, the cyclic voltammogram of the heme-
modified electrode shows symmetric oxidation and reduction
peaks. The formal potential (vs. Ag/AgCl/KCl) is approximate-
ly −0.295 V. The plot of peak current vs. scan rate is linear (Fig.
6, inset), and increases with increasing scan rate, as is typical for
Fig. 5. Schematic representation of immobilization of heme onto a gold electrode.
Fig. 6. Cyclic voltammogram of heme-modified electrode in 50 mM phosphate
buffer at pH 7.4 at 0.02 V/s scan rates. The inset shows the plot of current vs.
scan rate.
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peak separation is ∼0.111 V compared to 0.080 V in the heme
protein CV shown in Fig. 3.
2.3. Electrochemical response to the binding of N-donor
ligands
Earlier studies of heme/S824 showed that it bound carbon
monoxide [12], thereby demonstrating that the heme iron had a
displaceable axial ligand. The kinetics of CO association
indicated that the heme in S824 was partially buried [12],
consistent with the insensitivity of the formal potential to ionic
strength (see above). The ability of the heme in S824 to bind CO
in a semi-buried environment suggests that binding of
exogenous compounds might shift the potential of this heme
protein. To probe this possibility, we characterized the
electrochemical response of heme/S824C to the binding of
various imidazole and pyridine derivatives. These results are
then compared to the binding of the same compounds to isolated
heme.
2.3.1. Binding of imidazoles
Fig. 7a shows that the peaks in the CV of heme/S824C are
shifted to more negative potential by the presence of imidazole.
Similar shifts are seen in Fig. 7b for imidazole binding to
isolated heme. To assess how these shifts in the potential areaffected by modifications in the structure of the ligand, binding
was also evaluated for 1-methyl imidazole, 2-methyl imidazole,
and 4-methyl imidazole. As shown in Fig. 8, different imidazole
derivatives shifted the potential to different extents—both for
heme/S824C and for isolated heme. Moreover, the binding
properties of heme/S824C are somewhat different from those of
isolated heme. These results demonstrate several important
features.
Fig. 7. (a) Cyclic voltammetry of immobilized heme/S824C in the absence
(solid) and presence of 0.005 M (dotted) and 0.01 M imidazole (dashed) (scan
rate 0.02 V/s). (b) Cyclic voltammetry of immobilized heme in the absence
(solid) and presence of 0.005 M (dotted) and 0.01 M imidazole (dashed).
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between closely related imidazole compounds. The changes in
potential of heme/S824C and of isolated heme upon binding to
4 different imidazole derivatives are listed in Table 1. These
results demonstrate that both the heme/S-824C protein and the
isolated heme system respond differently to imidazole com-
pounds that differ from one another by the presence and location
of a single methyl group.
Second, heme/S824C binds both imidazole and 1-methyl
imidazole with greater affinity than does isolated heme. This
can be seen from the size of the potential shifts. As shown in
Fig. 8 and Table 1, imidazole at a concentration of 0.01 M shifts
the potential of heme/S824C by −0.096 V, but shifts the
potential of isolated heme by only −0.053 V. Likewise, for 1-
methyl imidazole (at 0.01 M), ΔEm is −0.045 for heme/S824C
and only −0.020 for isolated heme.
Third, heme/S824C binds 2-methyl imidazole with lower
affinity than does isolated heme. This can be seen from the
potential shifts in Fig. 8 and Table 1. ΔEm for 2-methyl
imidazole binding to heme/S824C is −0.032 V, while it is
−0.090 for binding to the isolated heme. For 4-methyl
imidazole, heme/S824C and isolated heme show little differ-
ence in binding.2.3.2. Binding of pyridines
As shown in Figs. 9 and 10, binding of pyridine and three
pyridine derivatives (2-aminopyridine, 3-aminopyridine, and 4-
cyanopyridine) shifts the reduction potential of heme/S824C
and of isolated heme. In contrast to what was observed for the
imidazole derivatives, the pyridine derivatives shift the potential
in the positive direction.
As was the case for the imidazole derivatives, both heme/
S824C and isolated heme readily distinguish the various
pyridine derivatives from one another (Fig. 10). Changes in
the potential of heme/S824C and of isolated heme in response to
the four different pyridine derivatives at 0.01 M concentration
are listed in Table 1.
In contrast to what was observed for the imidazole
derivatives, heme/S824C binds all the pyridine derivatives
less well than does the isolated heme. This is demonstrated by
the finding that binding pyridine (and its derivatives) produces
smaller shifts in potential for the heme protein than for the
isolated heme. These results suggest the protein scaffold may
partially block accessibility to the heme. For one derivative, 2-
aminopyridine, the protein scaffold seems to prevent binding
almost entirely. Thus, when 2-aminopyridine is added at a
concentration of 0.01 M, the midpoint potential of isolated
heme is shifted by 0.057 V, whereas the midpoint potential of
the heme/S-824C protein is nearly unchanged (Table 1).
2.3.3. Effect of ligand binding on the cyclic voltammogram of
heme/S824C
As shown in Figs. 7(a) and 9(a), binding of imidazoles and
pyridines causes the voltammogram peaks for heme/S824C not
only to shift, but also to broaden. The effects on the cathodic
and anodic peaks depend on the class of ligand. Imidazole
derivatives leave the cathodic peak sharp and shift it to more
negative values, while the anodic peak both shifts and broadens.
In contrast, addition of pyridine derivatives causes the opposite
behavior—the anodic peak remains sharp and shifts to more
positive values, while the cathodic peak both shifts and
broadens.
The shifts in potential are due to differential binding of ligand
by the oxidized and reduced states of heme protein (see
Discussion). The observed broadening may indicate that at high
concentration of ligand, a second equivalent binds to the heme.
The plots in Figs. 8 and 10 for heme–protein S824C indicate that
although m=1 for low concentrations of ligand, m appears to be
∼2 at higher concentration of ligand (m is the number of
exogenous ligand molecules bound to the heme). The occur-
rence of multiple heme-ligated species would cause heteroge-
neity in the system and lead to the broadening of the peaks.
Protein S824 is known to form a well-packed structure in the
apo-state [6]. However, since S824 was not explicitly designed
to bind heme, it would not be surprising if the binding site is
somewhat malleable. This could produce binding that is both
non-specific and relatively weak. At high concentrations of
exogenous ligand, the added ligand would compete with protein
side chains for binding to the heme iron. Thus, protein
flexibility might enable additional molecules of ligand to
penetrate the heme site of the protein, and modulate the redox
Fig. 8. Voltammetric titration of immobilized heme/S824C and isolated heme with imidazole derivatives. The observed net reduction potentials were plotted against
the logarithm of the concentration of ligand. The binding profiles are plotted for (a) imidazole (diamonds), (b) 1-methyl imidazole (circles), (c) 2-methyl-imidazole
(squares) and (d) 4-methyl imidazole (triangles). The curves are the computed nonlinear regression fit to the equation ΔEm=(mRT/F)ln[(1+Kred[S])/(1+Kox[S])]
where ΔEm=Ebound−Efree and m is the number of ligand molecules bound to the heme center. The ratio of the Kox/Kred obtained from the fit is listed in Table 1.
Table 1









Imidazole −0.096 V −0.053 V 23.437 20.00
1-Methyl
imidazole
−0.045 V −0.020 V 6.840 2.129
2-Methyl
imidazole
−0.032 V −0.090 V 4.600 24.651
4-Methyl
imidazole
−0.051 V −0.050 V 13.330 25.560
Pyridine 0.071 V 0.149 V 0.005 0.001
2-Aminopyridine 0.006 V 0.057 V 0.913 0.275
3-Aminopyridine 0.027 V 0.038 V 0.463 0.315
4-Cyanopyridine 0.065 V 0.093 V 0.220 0.080
The shifts in midpoint potential (ΔEm) upon addition of 0.01 M N-donor
compounds are shown as ΔEm where ΔEm=Ebound−Efree and Ebound and Efree
represent the reduction potentials in presence and absence of N-donor molecule
at 0.01 M concentration. Samples were at pH 7.4 and 50 mM PBS buffer. The
ratio of binding constants (Kox/Kred) is shown, where Kox and Kred represent
binding constants of oxidized and reduced forms of the heme in either heme/
S824C (column 4) or isolated heme (column 5). These values were obtained
from the nonlinear regression fit of the data in Figs. 8 and 10 to the equation
shown in the text.
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more heterogeneous manner than is seen for natural heme
proteins [21,22].
2.3.4. Differential binding of oxidized and reduced heme to N-
donor molecules
Our finding that each ligand has a somewhat different effect
on the reduction potential indicates that each of these small
molecules has a different effect on the equilibrium between the
oxidized and reduced states of heme. This in turn indicates that
each compound binds the oxidized and reduced states of the
heme protein with different relative affinities [23,24]. The
reduction potential of the heme–protein shifts to more negative
values on addition of imidazole, and to more positive potential
on addition pyridine. A negative shift in potential indicates that
the oxidized state is more stabilized than the reduced state,
while a positive shift indicates that binding stabilizes the
reduced state. Therefore, pyridine and its analogues stabilize the
ferrous (FeII) relative to the ferric (FeIII) state, whereas
imidazole and its analogues preferentially stabilize the ferric
(FeIII) state.
The shift in reduction potential is given by the following
equation:
DEm ¼ ðmRT=FÞln½ð1þ Kred½SÞ=ð1þ Kox½SÞwhere ΔEm=Ebound−Efree. Kred and Kox are the binding
constants of the reduced and oxidized forms of heme–protein
for the small molecules, m is the number of ligand molecules
Fig. 9. (a) Cyclic voltammetry of immobilized heme/S824C in the absence (solid)
and presence of 0.005M (dotted) and 0.01M pyridine (dashed) (scan rate 0.02 V/
s). (b) Cyclic voltammetry of immobilized heme in the absence (solid) and
presence of 0.005 M (dotted) and 0.01 M pyridine (dashed) (scan rate 0.02 V/s).
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10, the nonlinear regression fit to this equation enables
calculation of the ratios of Kox/Kred listed in Table 1.
3. Discussion
Protein S824C was derived from a library of sequences that
was not explicitly designed to bind heme. Thus, the electro-
chemical properties of heme/S824C can be considered as
‘default’ values for heme–proteins that were neither selected by
evolution nor designed computationally. These default proper-
ties can later be optimized for specified technological uses
though rational design and/or high throughput screening.
The high-resolution structure of S824 was solved in the apo-
state [6]. As per the binary code design strategy, the histidine
residues in this structure are exposed to solvent (Fig. 1). In the
presence of heme, however, these residues presumably adjust
their locations to accommodate the heme. While the heme site
in S824C is likely to be less buried than in natural heme proteins
like myoglobin, the relative insensitivity of the reduction
potential of heme/S824C to ionic strength suggests that the iron
is partially buried.
Binding of small N-donor molecules to this partially buried
heme shifts the potential of heme/S824C (Figs. 7–10). Theobserved shifts upon binding to heme/S824C were distinctly
different from the shifts observed upon binding of the same
compounds to isolated heme.
A shift in potential indicates that binding of the N-donor
ligand favors one redox state relative to the other. Several
factors are known to affect which state is stabilized by such
binding [23]. Shifts in potential are related both to the σ-donor/
π-acceptor properties of the ligand (affecting the enthalpic term)
and to the effect of water exclusion, which exerts a dual
enthalpic/entropic role. Additionally, the binding of N-donor
ligands by ferric and ferrous porphyrins depends on ligand
basicity. In the ferric porphyrin, the stability of the N-donor
heme complex increases with the basicity of the ligand and its
ability to donate electron density to the metal. In contrast, for the
more electron rich ferrous porphyrin, greater stability occurs for
ligands that have an electron withdrawing group and can accept
electron density from the metal. Thus, the reduction potential
becomes more negative with an increase in ligand basicity.
Pyridine and its derivatives are readily coordinated by
ferrous porphyrins as can be seen from the increase in the
reduction potential upon binding (Fig. 8). Both σ bonding from
the pyridine nitrogen to the iron and π-back-donation from the
iron to the ligand contribute to the strength of bonding. For
imidazole, σ-donor properties are much more significant than
π-acceptor properties when coordinating to ferrous porphyrins,
but imidazoles become better π-donors to ferric porphyrins
since they can donate to the hole in the dxz, dyz orbitals of the
iron in the ferric state. Hence, there is a direct correlation
between ligand basicity and the shift in heme potential on
coordination of N-donor molecules.
Our observation that heme/S-824C and isolated heme
respond differently shows that the protein scaffold modulates
the binding of N-donor ligands to the partially buried heme. Our
results can be compared to earlier studies using microperox-
idase, a 12-residue heme peptide (with no buried heme pocket),
which demonstrated that the redox potential of an immobilized
heme/peptide complex could be shifted by the presence of
imidazoles [21,22,25]. We see that the shift in the potential on
addition of N-donor ligands to heme/S-824C is less than it is for
microperoxidase but more than it is for myoglobin. This
suggests that protein S-824C is an intermediate case where the
heme binding site is more exposed than it is in myoglobin, but
less exposed than in microperoxidase.
The affinity of an iron porphyrin for N-donor ligands can be
modulated by steric effects and/or by hydrogen bonding with
residues near the binding site. Myoglobin, which has a buried
and well-ordered heme site, binds imidazole with a lower
affinity than does microperoxidase, with its solvent exposed
heme and open coordination site [26]. Exposure of the heme in
S824C is likely to be greater than in myoglobin, but less than in
microperoxidase or isolated heme. Heme/S824C binds imidaz-
ole and 1-methyl imidazole with greater affinity than does
isolated heme. This finding suggests that hydrogen bonding
interactions between imidazole (or 1-methyl imidazole) and the
protein scaffold of S824C may compensate for steric costs
associated with inserting the compound into the partially buried
site.
Fig. 10. Voltammetric titration of immobilized S-824-C/heme and isolated heme with pyridine derivatives. The observed net reduction potentials were plotted against
the logarithm of the concentration of ligand. The binding profiles are plotted for (a) pyridine (circles), (b) 2-aminopyridine (diamonds), (c) 4-cyanopyridine (squares)
and (d) 3-aminopyridine (triangles). The curves are the computed nonlinear regression fit to the equation ΔEm=(mRT/F)ln[(1+Kred[S])/(1+Kox[S])] where
ΔEm=Ebound−Efree and m is the number of ligand molecules bound to the heme center. The ratio of the Kox/Kred obtained from the fit is listed in Table 1.
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compound binds isolated heme better than S-824C/heme.
Apparently the methyl group on the 2 position sterically (or
otherwise) clashes with the protein scaffold.
For pyridine and its derivatives, binding to heme/S824C is
weaker than binding to isolated heme. Indeed, for 2-aminopyr-
idine the protein blocks binding entirely. Interference by the
protein scaffold with pyridine binding is similar to what has
been observed for myoglobin, which does not bind pyridine
[26]. Apparently, because pyridine cannot hydrogen bond to the
protein, it cannot overcome the steric cost associated with
insertion into a (partially) buried binding site.
3.1. Conclusions and future prospects
The experiments described above demonstrate that a de novo
protein from a designed binary patterned library (i) can be
immobilized on a gold electrode; (ii) binds heme; and (iii)
generates an electrochemical signal. Moreover, (iv) binding of
small molecules (pyridines and imidazoles) shifts the reduction
potential of heme–protein; (v) this shift in potential is sensitive
to changes in the concentration of the small molecules; and (vi)
responds differently to different pyridine and imidazole
derivatives. Additionally, (vii) the effect of binding of N-
donor molecules to heme/S824C is different from binding of thesame compounds to isolated heme, thereby demonstrating that
the scaffold of the de novo protein modulates the affinity of
small molecules for the heme moiety.
Natural heme proteins like myoglobin typically have heme
pockets that are buried and not readily accessible to N-donor
molecules. At the other extreme, heme bound peptides, such as
microperoxidase, have exposed hemes with unhindered binding
pockets, wherein the scaffold plays little role in binding. In
contrast, as shown above, de novo heme proteins from
combinatorial libraries can have intermediate properties where-
in the heme is not only accessible enough to allow binding, but
also embedded enough in the protein to enable the surrounding
residues to modulate binding and discriminate between different
small molecule analytes. These features can be exploited in
future work toward the design of biosensors that can detect and
discriminate between biologically relevant N-donor molecules
such as serotonin and histamine.
4. Materials and methods
4.1. Materials
Pyridine and imidazole were purchased from Merck. 4-
Cyanopyridine, 2-amino-pyridine, 3-aminopyridine, 1-methyl
imidazole, 2-methyl imidazole, 4-methyl-imidazole, cystamine
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dithiopropionic acid di-(N-succinimidyl ester), 3-carboxypropyl
disulphide and 1-ethyl-3-(3-dimethylaminopropyl)carbodii-
mide (EDC) were from Adrich-Sigma-Fluka. Heme (cholor-
oprotoporphyrin IX iron (III)) (H-5533) was from Aldrich-
Sigma-Fluka. The buffer salts (KH2PO4·3H2O and KH2PO4)
were of analytical grade and DMSO was obtained from Fisher
Scientific. N-Succinimidyl-3-maleimidopropionate was from
Pierce. The reference and auxiliary electrodes were from
Bioanalytical systems Inc. (West Lafayette, IN).
4.2. Mutagenesis of sequence S824 and protein expression
DNA encoding protein S824 was modified using PCR to
encode an additional glycine–glycine–cysteine tripeptide at the
C terminus of the protein sequence. The resulting protein,
S824C was expressed using the pET system in E. coli strain
BL21(DE3) [27], and purified using published methods
[5,6,28]. Dithiothreitol (DTT, 1 mM) was added to prevent
formation of disulphide bonds. Purified proteins were concen-
trated and buffer was exchanged into 50 mM sodium phosphate
buffer (pH 7.4) using Centricon Plus-20 filters (Biomax 5-
Millipore). Before immobilization on the maleimide modified
gold electrode, the protein was passed through a Pharmacia PD-
10 column to remove DTT. The oligomerization state of the
protein was assayed using size exclusion chromatography. The
protein was found to be mostly monomeric in the presence of
1 mM DTT. Expression and purification of protein were
evaluated by SDS-PAGE. Protein concentration was measured
by UV–VIS spectroscopy using a Hewlett Packard 8452A
diode array spectrophotometer.
4.3. Chemical modification of gold electrodes
Gold electrodes (0.5 mm diameter gold wire, geometrical
area 1.05 cm2) were cleaned as described by Katz and Solov'ev
[29]. CV recorded in 0.5 M sulfuric acid was used to determine
the purity of the electrode surface just before modification. The
cleaned gold electrode was modified by soaking in 100 mM
cystamine (2,2′-diaminodiethyldisulphide) in water for 2 h. The
electrode was then rinsed thoroughly with water to remove
physically adsorbed cystamine [30]. The electrode was further
modified by immersion for 2 h into a 1-mM solution of N-
succinimidyl-3-maleimidopropionate in DMSO [14] (Fig. 1).
4.4. Immobilization of protein onto the maleimide modified
gold electrode
The heme protein was immobilized in either of two ways:
(1) Incorporation of heme into a pre-immobilized protein:
The maleimide modified gold electrode was treated for
2 h with protein S824C (300 μM, in 50 mM sodium
phosphate buffer, pH 7.4). This was followed by rinsing
with water. The CV of the protein-modified electrode
(prior to addition of heme) was recorded as a control. It
showed no faradic response. Finally, the apo-protein layerwas converted to heme/S824C by soaking for 2 h in 1 mM
iron (III) choloroprotoporphyrin IX dissolved in 50 mM
sodium phosphate buffer (pH 7.4). [Stock solutions of
iron (III) choloroprotoporphyrin IX were made in 0.1 M
NaOH.]
(2) Immobilization of a pre-formed heme protein: Incorpo-
ration of Fe (III)-protoporphyrin IX into protein S824C
was accomplished in solution using a freshly prepared
stock solution of 1–2 M heme chloride (Sigma). Aliquots
of this stock solution were added to the protein samples
until the ratio of the Soret band at 413 nm to the free heme
band at 356 nm reached maximum Moffet et al. [13]. The
maleimide functionalized gold electrode (see above) was
then treated with this reconstituted protein for 4 h. The
advantage of this second method is that the potential
observed in the CV experiments must result from heme
bound to protein S824C, and not from heme bound on
cystamine or some other heme/electrode complex. Both
the methods of immobilization give similar results in the
cyclic voltammetry experiments.
4.5. Immobilization of heme on gold electrode
Heme was attached to the electrode using published methods
with minor modifications [20]. The cleaned electrodes were
immersed into a 100-mM solution of thiols in DMSO. After
incubation for 90 min at room temperature, the electrodes were
thoroughly rinsed with water and then immersed into 20 mM
1,12-diaminododecane. The C12 spacer (1,12 diaminodecane)
was used for all the proteins. After 4 h, the electrodes were
thoroughly washed with water and transferred to heme coupling
solution. Heme was dissolved in DMSO for a final concentra-
tion of 1 mM and then diluted 10 times in 10 mM pH 7.8
HEPES buffer containing 150 mM EDC (1-ethyl-3-(3-dimethy-
laminopropyl) carbodiimide) coupling agent. The heme cou-
pling was done overnight at 4 °C. The electrodes were rinsed
with distilled water.
4.6. Cyclic voltammetry
Cyclic voltammograms were recorded in 50 mM sodium
phosphate buffer at pH 7.4 using either a BAS 100B/W
Electrochemical Workstation or CH instruments model 660
electrochemical workstation. All measurements were performed
at ambient temperature (∼22 °C) in a conventional three-
compartment electrochemical cell consisting of the chemically
modified gold electrode as a working electrode, a platinum
auxiliary electrode and a saturated Ag/AgCl/KCl electrode as
the reference. Oxygen was removed from the solution in the
electrochemical cell by purging with Argon for several minutes
before recording the CV. All potentials are reported with respect
to the Ag/AgCl/KCl reference electrode.
4.7. Binding of ligands
Solutions of N-donor molecules were in milli-molar
concentrations (Table 1). The pH was maintained at 7.4 with
112 A. Das et al. / Biophysical Chemistry 123 (2006) 102–11250 mM phosphate buffer. Titrations of ligand were performed
by adding aliquots of each to 10 mL of buffer in the electrode
sample cell. Correction was not made for the effect of added
ligands on the pH value of the buffer solution. The sample cell
was purged thoroughly with Argon and each addition was
allowed to equilibrate for few minutes before recording the
cyclic voltammogram.
References
[1] L. Gorton, A. Lindgren, T. Larsson, F.D. Munteanu, T. Ruzgas, I.
Gazaryan, Direct electron transfer between heme-containing enzymes and
electrodes as basis of third generation biosensors, Anal. Chim. Acta 400
(1999) 91–108.
[2] P. McFadden, Broadband Biodetection: Holmes on a chip, Science 297
(2002) 2075–2077.
[3] H.W. Hellinga, J.S. Marvin, Protein engineering and the development of
generic biosensors, Trends Biotechnol. 16 (1998) 183–189.
[4] G. Gilardi, A. Fantuzzi, Manipulating redox systems: application to
nanotechnology, Trends Biotechnol. 19 (2001) 468–476.
[5] Y. Wei, T. Liu, S.L. Sazinsky, D.A. Moffet, I. Pelczer, M.H. Hecht, Stably
folded de novo proteins from a designed combinatorial library, Protein Sci.
12 (2003) 92–102.
[6] Y. Wei, S. Kim, D. Fela, J. Baum, M.H. Hecht, Solution structure of a de
novo protein from a designed combinatorial library, Proc. Natl. Acad. Sci.
U. S. A. 100 (2003) 13270–13273.
[7] S. Kamtekar, J.M. Schiffer, H. Xiong, J.M. Babik, M.H. Hecht, Protein
design by binary patterning of polar and nonpolar amino acids, Science
262 (1993) 1680–1685.
[8] M.W. West, W. Wang, J. Patterson, J.D. Mancias, J.R. Beasley, M.H.
Hecht, De novo amyloid proteins from designed combinatorial libraries,
Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 11211–11216.
[9] M.H. Hecht, A. Das, A. Go, L. Bradley, Y. Wei, De novo proteins from
designed combinatorial libraries, Protein Sci. 13 (2004) 1711–1723.
[10] N.R.L. Rojas, S. Kamtekar, C.T. Simons, J.E. McLean, K.M. Vogel, T.G.
Spiro, R.S. Farid, M.H. Hecht, De novo heme proteins from designed
combinatorial libraries, Protein Sci. 6 (1997) 2512–2524.
[11] D.A. Moffet, L.K. Certain, A.J. Smith, A.J. Kessel, K.A. Beckwith, M.H.
Hecht, Peroxidase activity in heme proteins derived from a designed
combinatorial library, J. Am. Chem. Soc. 122 (2000) 7612–7613.
[12] D.A. Moffet, M.A. Case, J.C. House, K. Vogel, R.D. Williams, T.G. Spiro,
G.L. McLendon, M.H. Hecht, Carbon monoxide binding by de novo heme
proteins derived from designed combinatorial libraries, J. Am. Chem. Soc.
123 (2001) 2109–2115.
[13] D.A. Moffet, J. Foley, M.H. Hecht, Midpoint reduction potentials and
heme binding stoichiometries of de novo proteins from designed
combinatorial libraries, Biophys. Chemist. 105 (2003) 231–239.
[14] I. Willner, V. Heleg-Shabtai, E. Katz, H.K. Rau, W. Haehnel, Integration of
a reconstituted de novo synthesized hemoprotein and native metallopro-
teins with electrode supports for bioelectronic and bioelectrocatalytic
applications, J. Am. Chem. Soc. 121 (1999) 6455–6468.
[15] E. Laviron, General expression of the linear potential sweep voltammo-
gram in the case of diffusionless electrochemical systems, J. Electroanal.
Chem. 101 (1979) 19–28.[16] E. Laviron, L.J. Roullier, General expression of the linear potential sweep
voltammogram for a surface redox reaction with interactions between the
adsorbed molecules: applications to modified electrodes, J. Electroanal.
Chem. 115 (1980) 65–74.
[17] D.L. Pilloud, X. Chen, P.L. Dutton, C.C. Moser, Electrochemistry of self-
assembled monolayers of iron protoporphyrin IX attached to modified gold
electrodes through thioether linkage, J. Phys. Chem., B 104 (2000)
2868–2877.
[18] D.K. Das, J. Medhi, The role of heme propionate in controlling the redox
potential of heme: square wave voltammetry of protoporphyrinato IX iron
(III) in aqueous surfactant micelles, J. Inorg. Biochem. 70 (1998) 83–90.
[19] P.D. Barker, J.L. Butler, P.D. Oliveira, H.A.O. Hill, N.I. Hunt, Direct
electrochemical studies of cytochrome b562, Inorg. Chim. Acta 252 (1996)
71–77.
[20] H. Zimmermann, A. Lindgren, W. Schuhmann, L. Gorton, Anisotropic
orientation of horseradish peroxidase by reconstitution on a thiol-modified
gold electrode, Chemistry 6 (2000) 592–599.
[21] H.M. Goldston, A.N. Scribner, S.A. Trammell, L.M. Tender, A model
recognition switch. Electrochemical control and transduction of imidazole
binding by electrode-immobilized microperoxidase-11, Chem. Commun. 7
(2002) 416–417.
[22] W. Zhang, F. Chunhai, S. Yuting, G. Li, An electrochemical investigation
of ligand-binding abilities of biomimetic membrane-entrapped myoglobin,
Biochim. Biophys. Acta Gen. Subj. 1623 (2003) 29–32.
[23] G. Battistuzzi, M. Borsari, J.A. Cowan, A. Ranieri, M. Sola, Control of
cytochrome c redox potential: axial ligation and protein environment
effects, J. Am. Chem. Soc. 124 (2002) 5315–5324.
[24] J.M. Shifman, B.R. Gibney, R.E. Sharp, P.L. Dutton, Heme redox potential
control in de novo designed four alpha helix bundle proteins, Biochemistry
39 (2000) 14813–14821.
[25] H.M. Marques, I. Cukrowski, P.R. Vashi, Coordination of weak field
ligands by N-acetylmicroperoxidase-8 (NAcMP8), a ferric haempeptide
from cytochrome c, and the influence of the axial ligand on the reduction
potential of complexes of NacMP8, J. Chem. Soc., Dalton Trans. 8 (2000)
1335–1342.
[26] C.B. Perry, T. Chick, A. Ntlokwana, G. Davies, H.M. Marques, The co-
ordination of ligands by iron porphyrins: a comparison of ligand binding
by myoglobin from sperm whale and the haem undecapeptide from
cytochrome c, J. Chem. Soc. Dalton Trans. 3 (2002) 449–457.
[27] F.W. Studier, A.H. Rosenberg, J.J. Dunn, J.W. Dubendorff, Use of T7
RNA polymerase to direct expression of cloned genes, Methods Enzymol.
185 (1990) 60–89.
[28] B.H. Johnson, M.H. Hecht, Recombinant proteins can be released from E.
coli cells by repeated cycles of freezing and thawing, Biotechnology 12
(1994) 1357–1360.
[29] E.Y. Katz, A.A. Solov'ev, Chemical modification of platinum and gold
electrodes by naphthoquinones using amines containing sulphhydryl or
disulphide groups, J. Electroanal. Chem. 291 (1990) 171–186.
[30] E.Y. Katz, D.D. Schlereth, H.L. Schmidt, Electrochemical study of
pyrroloquinoline quinone covalently immobilized as a monolayer onto a
cystamine-modified gold electrode, J. Electroanal. Chem. 367 (1994)
59–70.
